Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bristol-Myers Squibb Co BMY

Healthcare
Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule... see more

Recent & Breaking News (NYSE:BMY)

Bristol-Myers Squibb Announces European Patent Office Decision on Sprycel

Business Wire February 1, 2017

In Lockstep: Dow 20,000 Significance Magnified By Record Highs For SPX

Benzinga.com  January 26, 2017

The Market In 5 Minutes: Earnings, Trump And Dow20k

Benzinga.com  January 26, 2017

Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2016 Financial Results

Business Wire January 26, 2017

Bristol-Myers Squibb and Ono Pharmaceutical Company Enter Settlement and License Agreement with Merck to Resolve PD-1 Antibody Patent Litigation

Business Wire January 20, 2017

Mid-Day Market Update: Crude Oil Up 2.8%; Bristol-Myers Squibb Shares Slide After Opdivo Decision

Benzinga.com  January 20, 2017

Mid-Morning Market Update: Markets Open Higher; General Electric Revenue Misses Views

Benzinga.com  January 20, 2017

18 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  January 20, 2017

Bristol-Myers Squibb Provides Regulatory Update in First-line Lung Cancer

Business Wire January 19, 2017

Opdivo (nivolumab) Demonstrated Efficacy and Improved Survival in Patients with Previously Treated Advanced Gastric Cancer in a Randomized Phase 3 Study

Business Wire January 19, 2017

Trade Alerts: Bristol-Myers Squibb, Nordstrom, Netflix, Regions Financial Corporation and Constellation Brands trade ideas that offer returns of 23% or more!

PR Newswire January 6, 2017

Bristol-Myers Squibb and GeneCentric Diagnostics Announce Exploratory Biomarker Research Collaboration

Business Wire January 6, 2017

Bristol-Myers Squibb Announces Immunotherapy Clinical Collaboration with Janssen to Evaluate Opdivo (nivolumab) in Combination with Darzalex (daratumumab)

Business Wire January 5, 2017

Five Prime Therapeutics and Bristol-Myers Squibb Extend Research Term in Collaboration to Discover Novel Immuno-Oncology Therapies for Three Immune Checkpoint Pathways

GlobeNewswire January 4, 2017

Watch These 7 Huge Call Purchases In Wednesday Trade

Benzinga.com  January 4, 2017

Bristol-Myers Squibb to Present at J.P. Morgan Healthcare Conference

Business Wire January 3, 2017

Bristol-Myers Squibb to Take Part at the Goldman Sachs Healthcare CEOs Unscripted: A View from the Top

Business Wire December 29, 2016

Mid-Afternoon Market Update: Crude Oil Down 1.5%; Merus Shares Spike Higher

Benzinga.com  December 21, 2016

Mid-Morning Market Update: Markets Edge Lower; Finish Line Misses Q3 Expectations

Benzinga.com  December 21, 2016

Giovanni Caforio Named Chairman of Bristol-Myers Squibb’s Board of Directors

Business Wire December 21, 2016